insulin and glp 1 combo Fixed-ratio combination of GLP-1 receptor agonist basal insulin: simplifying type 2 diabetes treatment | Endocrine GLP-1 Medications – Community Education

Description

created the outline

Retatrutide Activates GIP, GLP-1, and Glucagon Receptors Research suggests retatrutide functions as: A GLP-1 receptor agonist A glucagon receptor agonist A glucose-dependent insulinotropic polypeptide receptor agonist This multi-pathway receptor activity may influence: Glucose metabolism Energy expenditure Appetite signaling Glycemic control Endocrine pathways Overall metabolic regulation Retatrutide also activates GIP receptor pathways that researchers believe may contribute to improved metabolic signaling and weight management outcomes

N=3,417

Maintaining cholesterol improvements with GLP-1 therapy depends on adherence and lifestyle support

Participants were patients with class II or III obesity treated with either MBS or GLP-1 RAs who were enrolled in Highmark insurance for at least 6 months prior to index treatment and had follow-up data available for at least 12 months